Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128593962> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3128593962 endingPage "199" @default.
- W3128593962 startingPage "196" @default.
- W3128593962 abstract "High doses or prolonged use of diclofenac, a commonly prescribed non-steroidal anti-inflammatory drug (NSAID), may result in gastrointestinal complications, which, if ignored, can be fatal. A preventable death attributed to diclofenac in a 16-year-old girl with complex needs has been identified, and is described in this article. Adverse drug reactions from NSAIDs should be considered and treated in children and adolescents, especially those with complex needs. > This article is part of the Coroners’ Concerns to Prevent Harms series.1 It discusses a Prevention of Future Death (PFD) report related to harm from diclofenac in an adolescent.2 Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is commonly prescribed for its analgesic, antipyretic and anti-inflammatory effects. About 658 000 prescriptions were dispensed for diclofenac in English primary care in the 12 months from September 2019 to August 2020, costing £8.3 million.3 Diclofenac is thought to exert its action by reducing prostaglandin synthesis through inhibition of the cyclo-oxygenase enzymes (COX-1 and COX-2). It is classified as a non-selective COX inhibitor, though in vitro studies have shown it preferentially inhibits COX-2 more than COX-1.4 Diclofenac is most commonly prescribed for pain relief but the specific indications for its use in children and adolescents vary by age, as recommended in the British National Formulary for Children, see box 1.5 Diclofenac, along with other NSAIDs, is associated with increased risks of bleeding, cardiovascular events, renal impairment and gastrointestinal complications, including peptic ulcer disease.6 These harms are well reported in the elderly, and NSAIDs have been implicated in 30% of all hospital admissions due to preventable adverse drug reactions (ADRs).7 However, the prevalence of such harms is not well studied in children and adolescents. Box 1 ### EBM facts: Information on diclofenac from the British National Formulary for Children #### Formulations #### Indications for use" @default.
- W3128593962 created "2021-02-15" @default.
- W3128593962 creator A5033917119 @default.
- W3128593962 creator A5043840157 @default.
- W3128593962 date "2021-02-10" @default.
- W3128593962 modified "2023-10-16" @default.
- W3128593962 title "Diclofenac in adolescents: diagnosing and treating gastrointestinal adverse drug reactions can prevent future deaths" @default.
- W3128593962 cites W1992746042 @default.
- W3128593962 cites W2011301426 @default.
- W3128593962 cites W2129481400 @default.
- W3128593962 cites W2131118525 @default.
- W3128593962 cites W2746736038 @default.
- W3128593962 cites W3108968855 @default.
- W3128593962 doi "https://doi.org/10.1136/bmjebm-2020-111640" @default.
- W3128593962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33568352" @default.
- W3128593962 hasPublicationYear "2021" @default.
- W3128593962 type Work @default.
- W3128593962 sameAs 3128593962 @default.
- W3128593962 citedByCount "11" @default.
- W3128593962 countsByYear W31285939622021 @default.
- W3128593962 countsByYear W31285939622022 @default.
- W3128593962 countsByYear W31285939622023 @default.
- W3128593962 crossrefType "journal-article" @default.
- W3128593962 hasAuthorship W3128593962A5033917119 @default.
- W3128593962 hasAuthorship W3128593962A5043840157 @default.
- W3128593962 hasBestOaLocation W31285939622 @default.
- W3128593962 hasConcept C126322002 @default.
- W3128593962 hasConcept C177713679 @default.
- W3128593962 hasConcept C197934379 @default.
- W3128593962 hasConcept C2426938 @default.
- W3128593962 hasConcept C2777628954 @default.
- W3128593962 hasConcept C2779252780 @default.
- W3128593962 hasConcept C2779826273 @default.
- W3128593962 hasConcept C2780035454 @default.
- W3128593962 hasConcept C2780820201 @default.
- W3128593962 hasConcept C2908765736 @default.
- W3128593962 hasConcept C71924100 @default.
- W3128593962 hasConcept C98274493 @default.
- W3128593962 hasConceptScore W3128593962C126322002 @default.
- W3128593962 hasConceptScore W3128593962C177713679 @default.
- W3128593962 hasConceptScore W3128593962C197934379 @default.
- W3128593962 hasConceptScore W3128593962C2426938 @default.
- W3128593962 hasConceptScore W3128593962C2777628954 @default.
- W3128593962 hasConceptScore W3128593962C2779252780 @default.
- W3128593962 hasConceptScore W3128593962C2779826273 @default.
- W3128593962 hasConceptScore W3128593962C2780035454 @default.
- W3128593962 hasConceptScore W3128593962C2780820201 @default.
- W3128593962 hasConceptScore W3128593962C2908765736 @default.
- W3128593962 hasConceptScore W3128593962C71924100 @default.
- W3128593962 hasConceptScore W3128593962C98274493 @default.
- W3128593962 hasIssue "4" @default.
- W3128593962 hasLocation W31285939621 @default.
- W3128593962 hasLocation W31285939622 @default.
- W3128593962 hasOpenAccess W3128593962 @default.
- W3128593962 hasPrimaryLocation W31285939621 @default.
- W3128593962 hasRelatedWork W1488844110 @default.
- W3128593962 hasRelatedWork W1982273085 @default.
- W3128593962 hasRelatedWork W2035205772 @default.
- W3128593962 hasRelatedWork W2073776458 @default.
- W3128593962 hasRelatedWork W2092936332 @default.
- W3128593962 hasRelatedWork W2102548330 @default.
- W3128593962 hasRelatedWork W2334372421 @default.
- W3128593962 hasRelatedWork W2591705055 @default.
- W3128593962 hasRelatedWork W1931066332 @default.
- W3128593962 hasRelatedWork W2182844372 @default.
- W3128593962 hasVolume "26" @default.
- W3128593962 isParatext "false" @default.
- W3128593962 isRetracted "false" @default.
- W3128593962 magId "3128593962" @default.
- W3128593962 workType "article" @default.